IDO1 and non-small cell lung carcinoma: Analysis of tumor tissue sections from patients with NSCLC (Fig. 3L; Supplementary Fig. S8A; Supplementary Table S9) and mouse models (Supplementary Fig. S8B) demonstrated a significant positive correlation between PRMT3 and IDO1 expression levels.